• Free Newsletters
  • Free Seminars and Podcasts from Industry Experts
  • Free Online Content and More

Lean budgets put the spotlight on Rx drug plans

By Lydell C. Bridgeford
August 6, 2009

To control the costs of prescription drug plans, more employers are focusing on cost sharing and low-price generic drugs, according to Buck Consultants’ second annual “Prescription Drug Benefit Survey.” 

The HR consulting firm completed the survey in July 2009, questioning more than 140 U.S.-based employers representing a broad range of industries and employer sizes.

“While the cost of prescription drug coverage varies widely, 30%, or the largest group of respondents, said pharmacy benefits represent between 11% and 15% of total health care costs,” says Michael Jacobs, a principal and national clinical practice leader at Buck Consultants. “This is down from last year’s survey, when the largest group indicated their drug benefits made up between 16 % and 20% of total health care costs,” he adds. The decrease may stem from more expensive brand medications moving off-patent and being replaced by lower-cost generics.

About 76% of respondents use employee cost sharing as a utilization management tool, up from 51% in 2008, Buck’s analysts found. The most common target cost-sharing range is 11% to 20% of claim costs, which was used by 39% of employers.

Overall, employers viewed their prescription drug benefits as a way to keep their workers healthy and to stay competitive in the marketplace.

The survey showed, however, that employers are not fully leveraging low-cost generic pricing as a cost management tool. For example, 73% of respondents report taking advantage of low-cost generic pricing offered by retail pharmacy chains as a high priority, while only 26% require their mail service provider to match these low-cost retail generic prices, Jacobs says.

Employers are also paying more attention to controlling the costs of specialty drugs. Nearly 60% of employers have included adherence to clinical guidelines as part of their specialty drug management programs. Based on the survey’s results, the top priorities in managing specialty drug therapies are:

  • Adherence to clinical guidelines
  • Clinical management
  • Coordination with case managers
  • Centralized distribution

Related coverage:

Switch to generic drugs yielded savings

Risky behavior: Employees scrimp on Rx costs

Related Articles

Most Popular

Most Forwarded